Evidence map›Paper›PMID 39111889›Full record

ArticleInternal medicine (Tokyo, Japan)2025

Danon Disease Presenting with Slowly Progressive Cardiomyopathy and Harboring a Novel Missense Variant in the Lysosome-associated Membrane Protein Type 2 (LAMP-2) Gene.

Yoichiro Nakagawa, Kenshi Hayashi, Takayasu Tada, Miwako Asakawa, Shohei Yoshida, Akihiro Nomura, Kenji Miwa, Hiroshi Furusho, Masayuki Takamura, Toshihiko Yasuda

Abstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yoichiro NakagawaDepartment of Cardiology, Ishikawa Prefectural Central Hospital, Japan.
Kenshi HayashiDepartment of Cardiovascular Medicine, Kanazawa University Hospital, Japan.
Takayasu TadaDepartment of Cardiology, Ishikawa Prefectural Central Hospital, Japan.
Miwako AsakawaDepartment of Neurology, Ishikawa Prefectural Central Hospital, Japan.
Shohei YoshidaDepartment of Cardiovascular Medicine, Kanazawa University Hospital, Japan.
Akihiro NomuraDepartment of Cardiovascular Medicine, Kanazawa University Hospital, Japan.
Kenji MiwaDepartment of Cardiology, Ishikawa Prefectural Central Hospital, Japan.
Hiroshi FurushoDepartment of Cardiology, Ishikawa Prefectural Central Hospital, Japan.
Masayuki TakamuraDepartment of Cardiovascular Medicine, Kanazawa University Hospital, Japan.
Toshihiko YasudaDepartment of Cardiology, Ishikawa Prefectural Central Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Danon disease (DD) is a rare lysosomal storage disorder resulting from pathogenic variants of the lysosome-associated membrane protein type 2 (LAMP-2) gene. The disease is characterized by severe cardiomyopathy, which rapidly progresses to end-stage heart failure. This case, with DD caused by a missense variant, exhibited slow progressive cardiomyopathy and survived for an extended period despite being a male. A pathological analysis revealed that only a minority of the samples exhibited autophagic vacuoles with unique sarcolemmal features, which are typical of DD. Importantly, LAMP-2 expression was absent and the myocardial tissue contained a substantial amount of p62-positive aggregates.

Indexed as

CardiomyopathiesGlycogen Storage Disease Type IIbLysosomal-Associated Membrane Protein 2Mutation, MissenseDisease ProgressionHumansLAMP2 protein, humanLysosomal-Associated Membrane Protein 2Danon diseaselysosome-associated membrane protein type 2 (LAMP-2) genemissense variantnext-generation sequencing

Identifiers

PMID39111889
PMCPMC11986313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.